A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels

Michael V Mandola(Rowan University), Robert D. Ladner, Syma Iqbal, Susan Groshen(American Society of Clinical Oncology), Wu Zhang, Jan Stoehlmacher(University Hospital Carl Gustav Carus), Mimi C. Yu(State Administration of Traditional Chinese Medicine of the People's Republic of China), Heinz‐Josef Lenz(University of Southern California)

Pharmacogenetics

April 27, 2004

10.1097/00008571-200405000-00007

Cited by 303

Related Papers

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

|The Lancet Oncology|2017|2.8k

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

|The Lancet|2019|2.6k

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

|Journal of Clinical Oncology|2018|2.1k

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

|The Lancet Oncology|2009|960

Epidemiology of nasopharyngeal carcinoma

|Seminars in Cancer Biology|2002|941